Trump's Cancer Research Cuts Jeopardize Moonshot

•1y ago

Trump's Cancer Research Cuts Jeopardize Moonshot

Tap title to read story

0:00 / 0:39

The Trump administration's actions have significantly hampered US cancer research. Funding cuts and grant terminations, particularly targeting programs with keywords like "trans," "diverse," and "women," have disrupted the Cancer Moonshot initiative. The NIH, CDC, and Department of Defense have experienced substantial funding reductions, impacting clinical trials and potentially delaying new treatments. While some grants have been reinstated by courts, the damage to research and researchers remains significant, jeopardizing progress toward reducing cancer deaths.

Published 2025-07-21 14:10:14 UTC · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

WIRED

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

•1h ago

New Beis Medrash Nears Completion

Tap title to read story

0:00 / 0:45

•1h ago

Burger King’s Peppercorn BLT Whopper

Tap title to read story

0:00 / 0:36

•1h ago

Oregon Ducks Fire Offensive Coordinator

Tap title to read story

0:00 / 0:34

1/3

•3h ago

Big Tech Acquisitions Trigger Antitrust Scrutiny

Tap title to read story

0:00 / 0:26

•3h ago

Tech Coalition Pushes Federal Preemption

Tap title to read story

A powerful coalition of federal legislators, executive branch officials, and multinational technology corporations has coalesced around a strategy of "federal preemption," seeking to strip state governments of their authority over generative AI. The coalition argues that the legal frameworks governing these technologies are in a state of flux as generative AI affects every sector of the economy, from healthcare diagnostics to creative industries. The push aims to centralize regulation at the federal level, limiting state‑level oversight of AI development and deployment.

0:00 / 0:32